This Funding Opportunity Announcement invites applications for the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network. The grant aims to establish comprehensive, cooperative research Centers focused on developing strategies against potential pandemic pathogens. Specifically, it targets prototype members from the Bunyavirales, Paramyxoviridae, and Picornaviridae virus families. The core objective is to advance vaccine and monoclonal antibody solutions for these prototypes, with findings applicable to closely related virus family members based on shared properties. This initiative seeks to foster in-depth basic and translational research to enhance global preparedness against emerging viral threats.
Opportunity ID: 346910
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-23-020 |
| Funding Opportunity Title: | Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 16, 2023 |
| Last Updated Date: | Mar 16, 2023 |
| Original Closing Date for Applications: | Jun 08, 2023 |
| Current Closing Date for Applications: | Jun 08, 2023 |
| Archive Date: | Jul 14, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $10,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses County governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education City or township governments Small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Special district governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to participate in the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network. The purpose of this FOA is to establish comprehensive, cooperative basic and translational research Centers to carry out in-depth research on prototype members of select virus families that have the potential to emerge as pandemic pathogens. The goal of these Centers will be to develop vaccine and monoclonal antibody strategies for prototype pathogen(s) that can be applied to closely related family members based on shared functional and structural properties. This FOA solicits for centers proposing research on virus families from Bunyavirales, Paramyxoviridae and Picornaviridae to be part of the ReVAMPP Network. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-020.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 346910 Full Announcement-RFA-AI-23-020 -> RFA-AI-23-020-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00280594 | May 08, 2023 | Jun 08, 2023 | View |
Package 1
Mandatory forms
346910 RR_SF424_5_0-5.0.pdf
346910 PHS398_CoverPageSupplement_5_0-5.0.pdf
346910 RR_OtherProjectInfo_1_4-1.4.pdf
346910 PerformanceSite_4_0-4.0.pdf
346910 RR_KeyPersonExpanded_4_0-4.0.pdf
346910 PHS398_ResearchPlan_5_0-5.0.pdf
346910 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
346910 PHS_Additional_IndirectCosts_2_0-2.0.pdf
346910 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
